2-(6-(4-((6-aminopyridin-3-yl)sulfonyl)piperazin-1-yl)-5-chloropyridin-3-yl)-1,1,1,3,3,3-hexafluoropropan-2-ol

ID: ALA3319523

PubChem CID: 118709613

Max Phase: Preclinical

Molecular Formula: C17H16ClF6N5O3S

Molecular Weight: 519.86

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc(S(=O)(=O)N2CCN(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cc3Cl)CC2)cn1

Standard InChI:  InChI=1S/C17H16ClF6N5O3S/c18-12-7-10(15(30,16(19,20)21)17(22,23)24)8-27-14(12)28-3-5-29(6-4-28)33(31,32)11-1-2-13(25)26-9-11/h1-2,7-9,30H,3-6H2,(H2,25,26)

Standard InChI Key:  XBUBRXIUOXRHDZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    6.2032   -3.5329    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0204   -3.5370    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.6154   -2.8273    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3215   -4.7669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3204   -5.5864    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0284   -5.9954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7381   -5.5860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7352   -4.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0266   -4.3581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0282   -6.8126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7307   -3.1302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4438   -3.5366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1482   -3.1293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1499   -2.3118    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4412   -1.9031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7306   -2.3120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8552   -1.9063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5629   -2.3171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2704   -1.9098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2715   -1.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5592   -0.6827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8545   -1.0924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9790   -0.6828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6869   -1.0910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9786    0.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6830   -0.2683    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6874   -1.9082    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.3944   -0.6820    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.3887   -1.4982    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.6861    0.5462    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.2706    0.5469    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.9731    0.9534    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.5614   -3.1343    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  6 10  1  0
  9  2  1  0
  2 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 14 17  1  0
 20 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
 24 27  1  0
 24 28  1  0
 24 29  1  0
 25 30  1  0
 25 31  1  0
 25 32  1  0
 18 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3319523

    ---

Associated Targets(Human)

GCK Tchem Hexokinase type IV (3191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gck Glucokinase (92 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 519.86Molecular Weight (Monoisotopic): 519.0567AlogP: 2.54#Rotatable Bonds: 4
Polar Surface Area: 112.65Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.26CX Basic pKa: 4.06CX LogP: 2.42CX LogD: 2.04
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.60Np Likeness Score: -1.38

References

1. Hong FT, Norman MH, Ashton KS, Bartberger MD, Chen J, Chmait S, Cupples R, Fotsch C, Jordan SR, Lloyd DJ, Sivits G, Tadesse S, Hale C, St Jean DJ..  (2014)  Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 4. Exploration of a novel binding pocket.,  57  (14): [PMID:25001129] [10.1021/jm5001979]
2. Xu, Jiayi J and 25 more authors.  2017-05-01  Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus.  [PMID:28284809]
3. May-Dracka, Tricia L TL and 21 more authors.  2018-06-01  Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunity.  [PMID:29636220]
4. Narayan, Satya S and 7 more authors.  2019-01-01  ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.  [PMID:30384048]
5. Hinklin, Ronald J and 18 more authors.  2020-01-01  Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator.  [PMID:31818630]

Source